DrugPatentWatch Database Preview
CARNITOR Drug Profile
» See Plans and Pricing
Which patents cover Carnitor, and when can generic versions of Carnitor launch?
Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. There are three patents protecting this drug.
This drug has four patent family members in four countries.
The generic ingredient in CARNITOR is levocarnitine. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levocarnitine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carnitor
A generic version of CARNITOR was approved as levocarnitine by WEST-WARD PHARMS INT on March 29th, 2001.
Summary for CARNITOR
| International Patents: | 4 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 96 |
| Clinical Trials: | 4 |
| Patent Applications: | 3,529 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CARNITOR |
| What excipients (inactive ingredients) are in CARNITOR? | CARNITOR excipients list |
| DailyMed Link: | CARNITOR at DailyMed |
Recent Clinical Trials for CARNITOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Physicians' Services Incorporated Foundation | Phase 4 |
| University Health Network, Toronto | Phase 4 |
| Montefiore Medical Center | Phase 2/Phase 3 |
Pharmacology for CARNITOR
| Drug Class | Carnitine Analog |
US Patents and Regulatory Information for CARNITOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Leadiant Biosci Inc | CARNITOR SF | levocarnitine | SOLUTION;ORAL | 019257-002 | Mar 28, 2007 | AA | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Leadiant Biosci Inc | CARNITOR | levocarnitine | SOLUTION;ORAL | 018948-002 | Apr 27, 1988 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARNITOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARNITOR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 3050201 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0152836 | Start Trial |
| European Patent Office | 1257266 | Start Trial |
| Canada | 2381187 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
